<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://articlefeeds.nasdaq.com/~d/styles/itemcontent.css"?><rss xmlns:a10="http://www.w3.org/2005/Atom" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
  <channel xmlns:nasdaq="http://nasdaq.com/reference/feeds/1.0/">
    <title>Latest Articles about CLSN</title>
    <description />
    <language>EN-US</language>
    <lastBuildDate>Thu, 23 May 2013 19:24:18 -0400</lastBuildDate>
    <atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://articlefeeds.nasdaq.com/nasdaq/symbols?symbol=CLSN" /><feedburner:info uri="nasdaq/symbols" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item xml:base="http://www.nasdaq.com/article/how-the-bulls-are-sticking-with-celsion-cm192992">
      <guid isPermaLink="false">192992</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BXEnKAoTHSs/how-the-bulls-are-sticking-with-celsion-cm192992</link>
      <category>Investing</category>
      <category>Options</category>
      <title>How the bulls are sticking with Celsion</title>
      <description>Celsion has been explosive, and traders remain bullish on the stock.    optionMONSTER's Heat Seeker monitoring programs detected the purchase of 2,250 February 12 calls for $1. Some 1,500&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/BXEnKAoTHSs" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 26 Nov 2012 20:52:55 Z</pubDate>
      <a10:updated>2012-11-26T17:35:34Z</a10:updated>
      <author>David Russell</author>
      <nasdaq:tickers>CLSN</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/how-the-bulls-are-sticking-with-celsion-cm192992</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/bull-looks-for-more-gains-in-celsion-cm191989">
      <guid isPermaLink="false">191989</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X7_T9mtXL-k/bull-looks-for-more-gains-in-celsion-cm191989</link>
      <category>Investing</category>
      <category>Options</category>
      <title>Bull looks for more gains in Celsion</title>
      <description>Celsion has been rallying, and one investor is staying in the trade while looking for more upside.    optionMONSTER's Heat Seeker monitoring program detected the sale of 5,000 January 7 calls for&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/X7_T9mtXL-k" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 21 Nov 2012 22:16:28 Z</pubDate>
      <a10:updated>2012-11-21T18:34:39Z</a10:updated>
      <author>David Russell</author>
      <nasdaq:tickers>CLSN</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/bull-looks-for-more-gains-in-celsion-cm191989</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/largest-option-buying-in-equities-so-far-cm191942">
      <guid isPermaLink="false">191942</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qa0-66qnd84/largest-option-buying-in-equities-so-far-cm191942</link>
      <category>Investing</category>
      <category>Options</category>
      <title>Largest option buying in equities so far</title>
      <description>Nearing the halfway mark in today's session, here are the individual equity names with the most call and put buying on optionMONSTER's ActionTracker data system.    Merck (MRK): An investor sold&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/qa0-66qnd84" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 21 Nov 2012 21:33:44 Z</pubDate>
      <a10:updated>2012-11-21T17:36:16Z</a10:updated>
      <author>David Russell</author>
      <nasdaq:tickers>CLSN</nasdaq:tickers>
      <nasdaq:tickers>FB</nasdaq:tickers>
      <nasdaq:tickers>MRK</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/largest-option-buying-in-equities-so-far-cm191942</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/premarket-earnings-report-for-november-12-2012-dhi-cyd-bzh-clsn-rrst-ctib-cm188823">
      <guid isPermaLink="false">188823</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ahEKo478yrk/premarket-earnings-report-for-november-12-2012-dhi-cyd-bzh-clsn-rrst-ctib-cm188823</link>
      <category>News Headlines</category>
      <category>Earnings</category>
      <title>Pre-Market Earnings Report for November 12, 2012 :  DHI, CYD, BZH, CLSN, RRST, CTIB</title>
      <description>The following companies are expected to report earnings prior to market open on 11/12/2012. Visit our  Earnings Calendar  for a full list of expected earnings releases.   D.R. Horton, Inc.  (&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/ahEKo478yrk" height="1" width="1"/&gt;</description>
      <pubDate>Sat, 10 Nov 2012 02:00:04 Z</pubDate>
      <a10:updated>2012-11-09T21:16:39Z</a10:updated>
      <author>NASDAQ.com News</author>
      <nasdaq:tickers>BZH</nasdaq:tickers>
      <nasdaq:tickers>CLSN</nasdaq:tickers>
      <nasdaq:tickers>CTIB</nasdaq:tickers>
      <nasdaq:tickers>CYD</nasdaq:tickers>
      <nasdaq:tickers>DHI</nasdaq:tickers>
      <nasdaq:tickers>RRST</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/premarket-earnings-report-for-november-12-2012-dhi-cyd-bzh-clsn-rrst-ctib-cm188823</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/weekly-ceo-buys-highlight-nihd-rent-vtnc-mdw-cm175910">
      <guid isPermaLink="false">175910</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cCpMiceTMH8/weekly-ceo-buys-highlight-nihd-rent-vtnc-mdw-cm175910</link>
      <category>Investing</category>
      <title>Weekly CEO Buys Highlight: NIHD, RENT, VTNC, MDW</title>
      <description>According to  GuruFocus Insider Data  , these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below:     NII Holdings Inc. (  NIHD  ): CEO&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/cCpMiceTMH8" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 24 Sep 2012 18:34:27 Z</pubDate>
      <a10:updated>2012-09-24T18:42:03Z</a10:updated>
      <author>GuruFocus</author>
      <nasdaq:tickers>CLSN</nasdaq:tickers>
      <nasdaq:tickers>NIHD</nasdaq:tickers>
      <nasdaq:tickers>RENT</nasdaq:tickers>
      <nasdaq:tickers>USA</nasdaq:tickers>
      <nasdaq:tickers>VTNC</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/weekly-ceo-buys-highlight-nihd-rent-vtnc-mdw-cm175910</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/whatever-you-do-dont-sell-this-surging-stock-cm174899">
      <guid isPermaLink="false">174899</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yGQA-hVfLig/whatever-you-do-dont-sell-this-surging-stock-cm174899</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <title>Whatever you Do, Don't Sell This Surging Stock</title>
      <description>It's been roughly one month since  I added  shares of  Celsion (Nasdaq:  CLSN  )  to my    $100,000 Real-Money Portfolio    , and they're already up nearly 25%.   In fact, this stock has&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/yGQA-hVfLig" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 18 Sep 2012 22:00:00 Z</pubDate>
      <a10:updated>2012-09-20T05:34:09Z</a10:updated>
      <author>David Sterman</author>
      <nasdaq:tickers>CLSN</nasdaq:tickers>
      <nasdaq:tickers>PSTI</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/whatever-you-do-dont-sell-this-surging-stock-cm174899</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/investing-in-biotech-stocks-the-journey-to-profits-requires-a-good-gps-cm169161">
      <guid isPermaLink="false">169161</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gVY8kCh8q9o/investing-in-biotech-stocks-the-journey-to-profits-requires-a-good-gps-cm169161</link>
      <category>Investing</category>
      <category>Stocks</category>
      <category>Investing Ideas</category>
      <category>Technology</category>
      <title>Investing in Biotech Stocks? The Journey to Profits Requires a Good GPS</title>
      <description>Small biotech stocks are trendy. Let’s face it, the rewards to a company that introduces the next wonder drug for cancer, obesity or dementia are huge. From a trader’s perspective, these massive&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/gVY8kCh8q9o" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 31 Aug 2012 20:21:37 Z</pubDate>
      <a10:updated>2012-08-31T16:39:33Z</a10:updated>
      <author>OptionsANIMAL</author>
      <nasdaq:tickers>ARNA</nasdaq:tickers>
      <nasdaq:tickers>CLSN</nasdaq:tickers>
      <nasdaq:tickers>CLVS</nasdaq:tickers>
      <nasdaq:tickers>OREX</nasdaq:tickers>
      <nasdaq:tickers>ZLCS</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/investing-in-biotech-stocks-the-journey-to-profits-requires-a-good-gps-cm169161</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/even-after-a-big-run-this-biotech-pick-has-ample-upside-cm165863">
      <guid isPermaLink="false">165863</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iQbaDyayeoI/even-after-a-big-run-this-biotech-pick-has-ample-upside-cm165863</link>
      <category>Investing</category>
      <category>Basics</category>
      <category>Commodities</category>
      <title>Even After a Big Run, This Biotech Pick Has Ample Upside</title>
      <description>For readers who have not been following our newsletter editors for an extended period, it's time to acquaint you with a longstanding policy: We never buy a stock for one of our portfolios for 2&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/iQbaDyayeoI" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 20 Aug 2012 23:00:00 Z</pubDate>
      <a10:updated>2012-08-22T06:32:08Z</a10:updated>
      <author>David Sterman</author>
      <nasdaq:tickers>CLSN</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/even-after-a-big-run-this-biotech-pick-has-ample-upside-cm165863</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/this-biotechs-cancerfighting-treatment-could-lead-the-stock-to-tripledigit-gains-cm165125">
      <guid isPermaLink="false">165125</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JfYnvJhe97Y/this-biotechs-cancerfighting-treatment-could-lead-the-stock-to-tripledigit-gains-cm165125</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <title>This Biotech's Cancer-Fighting Treatment Could Lead the Stock to Triple-Digit Gains</title>
      <description>Readers of my articles know I spend little time focusing on biotech stocks. The science behind these companies is often so arcane that analyzing these firms to find the best stocks to invest in&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/JfYnvJhe97Y" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 16 Aug 2012 20:00:00 Z</pubDate>
      <a10:updated>2012-08-18T07:21:34Z</a10:updated>
      <author>David Sterman</author>
      <nasdaq:tickers>CLSN</nasdaq:tickers>
      <nasdaq:tickers>HRZN</nasdaq:tickers>
      <nasdaq:tickers>PHG</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/this-biotechs-cancerfighting-treatment-could-lead-the-stock-to-tripledigit-gains-cm165125</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/my-next-great-biotech-stock-pick-could-easily-triple-cm152430">
      <guid isPermaLink="false">152430</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rXYfsursSwE/my-next-great-biotech-stock-pick-could-easily-triple-cm152430</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <title>My Next Great Biotech Stock Pick Could Easily Triple</title>
      <description>Biotech investing is awfully tricky. For every stock pick that performs well, a number of others blow up. From increasingly tough hurdles with clinical trials to the mercurial rulings of the Food&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/rXYfsursSwE" height="1" width="1"/&gt;</description>
      <pubDate>Thu, 28 Jun 2012 16:30:00 Z</pubDate>
      <a10:updated>2012-06-30T06:11:34Z</a10:updated>
      <author>David Sterman</author>
      <nasdaq:tickers>CLSN</nasdaq:tickers>
      <nasdaq:tickers>HCC</nasdaq:tickers>
      <nasdaq:tickers>MDVN</nasdaq:tickers>
      <nasdaq:tickers>THLD</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/my-next-great-biotech-stock-pick-could-easily-triple-cm152430</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/my-top-5-smallcap-stocks-to-own-right-now-cm139831">
      <guid isPermaLink="false">139831</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d6NRiSWHpYQ/my-top-5-smallcap-stocks-to-own-right-now-cm139831</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <title>My Top 5 Small-Cap Stocks to Own Right Now</title>
      <description>It's crucial to avoid the trap of focusing on the same types of investments for your portfolio. Investors tend to focus on large caps, small caps or dividend-paying stocks exclusively, when they&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/d6NRiSWHpYQ" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 07 May 2012 16:30:00 Z</pubDate>
      <a10:updated>2012-05-09T05:15:17Z</a10:updated>
      <author>David Sterman</author>
      <nasdaq:tickers>CLSN</nasdaq:tickers>
      <nasdaq:tickers>CVO</nasdaq:tickers>
      <nasdaq:tickers>GFA</nasdaq:tickers>
      <nasdaq:tickers>HL</nasdaq:tickers>
      <nasdaq:tickers>WEN</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/my-top-5-smallcap-stocks-to-own-right-now-cm139831</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/up-150-in-4-months-this-stock-could-double-again-cm119581">
      <guid isPermaLink="false">119581</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mTtKQu_Ee20/up-150-in-4-months-this-stock-could-double-again-cm119581</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <title>Up 150% in 4 Months, This Stock Could Double Again</title>
      <description>I've noted on a few occasions that investing in   shares   of biotech companies is quite challenging for the average investor. In this case, as   I suggested   a few weeks ago, a biotech fund may&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/mTtKQu_Ee20" height="1" width="1"/&gt;</description>
      <pubDate>Tue, 07 Feb 2012 20:00:00 Z</pubDate>
      <a10:updated>2012-02-09T06:05:18Z</a10:updated>
      <author>David Sterman</author>
      <nasdaq:tickers>CLSN</nasdaq:tickers>
      <nasdaq:tickers>MDVN</nasdaq:tickers>
      <nasdaq:tickers>THLD</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/up-150-in-4-months-this-stock-could-double-again-cm119581</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/trader-braves-steep-drop-in-celsion-cm105256">
      <guid isPermaLink="false">105256</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zvmahxKwZPM/trader-braves-steep-drop-in-celsion-cm105256</link>
      <category>Investing</category>
      <category>Options</category>
      <title>Trader braves steep drop in Celsion</title>
      <description>One big investor isn't scared of a drop in Celsion.        The micro-cap drug developer is down 11 percent to $2.49 today. It's not clear why shares are down, but the drop came after CLSN said it&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/zvmahxKwZPM" height="1" width="1"/&gt;</description>
      <pubDate>Mon, 28 Nov 2011 20:39:29 Z</pubDate>
      <a10:updated>2011-11-28T17:06:37Z</a10:updated>
      <author>David Russell</author>
      <nasdaq:tickers>CLSN</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/trader-braves-steep-drop-in-celsion-cm105256</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/3-cancerfighting-stocks-that-could-deliver-huge-gains-cm97584">
      <guid isPermaLink="false">97584</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vyW4HLMZX5w/3-cancerfighting-stocks-that-could-deliver-huge-gains-cm97584</link>
      <category>Investing</category>
      <category>Investing Ideas</category>
      <title>3 Cancer-Fighting Stocks That Could Deliver Huge Gains</title>
      <description>Here's a bit of good news. With millions of Americans now taking anticholesterol drugs (known as statins), heart disease may soon lose its status as the leading cause of deaths in the United&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/vyW4HLMZX5w" height="1" width="1"/&gt;</description>
      <pubDate>Fri, 07 Oct 2011 17:00:00 Z</pubDate>
      <a10:updated>2011-10-09T05:01:20Z</a10:updated>
      <author>David Sterman</author>
      <nasdaq:tickers>CLSN</nasdaq:tickers>
      <nasdaq:tickers>MDVN</nasdaq:tickers>
      <nasdaq:tickers>PFE</nasdaq:tickers>
      <nasdaq:tickers>THLD</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/3-cancerfighting-stocks-that-could-deliver-huge-gains-cm97584</feedburner:origLink></item>
    <item xml:base="http://www.nasdaq.com/article/update-top-unusual-option-activity-cm86226">
      <guid isPermaLink="false">86226</guid>
      <link>http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ml-AXlRDzyQ/update-top-unusual-option-activity-cm86226</link>
      <category>Investing</category>
      <category>Options</category>
      <title>Update: Top unusual option activity</title>
      <description>As of today's market close, here are the top 10 names showing unusual option activity on tradeMONSTER's LiveAction data system.&amp;#160;        Celsion (CLSN): Option volume 2,125 percent above&lt;img src="http://feeds.feedburner.com/~r/nasdaq/symbols/~4/Ml-AXlRDzyQ" height="1" width="1"/&gt;</description>
      <pubDate>Wed, 20 Jul 2011 01:45:58 Z</pubDate>
      <a10:updated>2011-07-19T23:24:16Z</a10:updated>
      <author>David Russell</author>
      <nasdaq:tickers>CLSN</nasdaq:tickers>
      <nasdaq:tickers>NWS</nasdaq:tickers>
      <nasdaq:tickers>NWSA</nasdaq:tickers>
      <nasdaq:tickers>PG</nasdaq:tickers>
      <nasdaq:tickers>TZOO</nasdaq:tickers>
    <feedburner:origLink>http://www.nasdaq.com/article/update-top-unusual-option-activity-cm86226</feedburner:origLink></item>
  </channel>
</rss>
